Burden of disease related to Parkinson's disease in Spain in the year 2000

Movement Disorders

Volumn 20, Issue 11, 2005, Pages 1481-1487

  Cubo, Esther ^a   Alvarez, Elena ^a   Morant, Consuelo ^a   de Pedro Cuesta, Jesús ^a   Martín, Pablo Martínez ^a   Génova, Ricard ^a   Freire, José Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Burden of disease; DALY; Disability; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; DISABILITY; DISEASE SEVERITY; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARKINSON DISEASE; POPULATION SIZE; PRIORITY JOURNAL; QUALITY OF LIFE; SPAIN; WORLD HEALTH ORGANIZATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DISABLED PERSONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY-ADJUSTED LIFE YEARS; SEVERITY OF ILLNESS INDEX; SPAIN; WORLD HEALTH ORGANIZATION;

EID: 30544441510     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20622     Document Type: Article

References (48)

1. Kuopio AM, Marttila RJ, Helenius M, et al. The quality of life in Parkinson's disease. Mov Disord 2000;15:216-223.
2. Carter JH, Stewart PG, Archbold PG, et al. Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease. Parkinson's study group. Mov Disord 1998;13:20-28.
3. Janca A. Parkinson's disease from WHO perspective and a public health point of view. Parkinsonism Relat Disord 2002;9:3-6.
4. Guttman M, Slaughter P, Theriault ME, et al. Burden of parkinsonism: a population-based study. Mov Disord 2003;18:313-316.
5. Olesen J, Leonardi M. The burden of brain diseases in Europe. Eur J Neurol 2003;10:471-477.
6. Murray CJL, López AD. Evidence-based health policy-lessons from the Global Burden of Disease study. Science 1996;274:740-743.
7. Murray CJL, Ferguson B, López AD, Guillot M, Salomon JA, Ahmad O. Modified-logit life table system: principles, empirical validation and application. Geneva: World Health Organization; 2001 (GPE Discussion Paper No 39).
8. Murray CJL, López AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press; 1996.
9. World Bank. World development report 1993; investing in health. New York: Oxford University Press for the World Bank; 1993.
10. World Health Organization (WHO) (1992-1994). International statistical classification of diseases and related health problems. 10th revision. ICD-10. Vol. 1-3. Geneva: World Health Organization.
11. INE. Fichero de microdatos individuales de defunciones con causa muerte. Madrid: Instituto Nacional de Estadística; 2000.
12. Coale A, Guo G. Revised regional model life tables at very low levels of mortality. Popul Index 1989;55:613-643.
13. Proyecciones de la población de España calculadas a partir del censo de población de 1991. Evaluación y revisión. Total nacional 1990-2050. Comunidades Autónomas y provincias 1990-2050. Madrid: Instituto Nacional de Estadística; 2001.
14. Benito-León J, Bermejo-Pareja F, Morales-Gonzalez JM, et al. Incidence of Parkinson's disease and parkinsonism in three elderly populations of central Spain. Neurology 2004;62:734-741.
15. Granieri E, Carreras M, Asetta I, et al. Parkinson's disease in Ferrara, Italy 1967 through 1987. Arch Neurol 1991;48:854-857.
16. Baldereschi M, Di Carlo A, Rocca WA, et al. Parkinson's disease and parkinsonism in a longitudinal study. Two-fold higher incidence in men. Neurology 2000;55:1358-1363.
17. Wood S.N. Modelling and smoothing parameter estimation with multiple quadratic penalties. J R. Statist Soc B 2000;62:413-428.
18. Wood SN. Thin plate regression splines. J R Statist Soc B 2003; 65:95-114.
19. Roos RAC, Jongen JCF, van der Velde EA. Clinical course of patients with idiopathic Parkinson's disease. Mov Disord 1996;11: 236-242.
20. Murray CJL, Lopez A. In: The global burden of disease. Vol. I. Boston: Harvard University Press; 1996. p 412-416.
21. Stouthard MEA, Essink-Bot ML, Bonsel GJ, et al. Disability weights for diseases in the Netherlands. The Netherlands: Department of Public Health, Erasmus University Rotterdam; 1997.
22. Public Health Division. Victorian Government Department of Human Services. Victoria Burden of Diseases Study: morbidity. Melbourne, Victoria: Victorian Government Department of Human Services; 1999.
23. The World Health report 2001. Mental health: new understanding, new hope. Geneva: World Health Organization; 2001.
24. United Nations. World population prospects: the 2000 revision. New York: Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat; 2001.
25. GesMor: Software developed by the International Health Department, Instituto de Salud Carlos III. Supported by the Health Mexican Foundation (FUNSALUD) and the Interamerican Bank for Development. Available at: http://www.funsalud.org.mx/red-jlb/gesmor.htm.
26. DisMod II. Software developed by J. Barendregt, Department of Public Health. Erasmus University Holland. In collaboration with the WHO. Available at: http://www.hsph.harvard.edu/Organizations/bdu/DisMod.html.
27. Sanders BS. Measuring community health levels. Am J Public Health 1964;54:1063-1070.
28. Sullivan DF. A single index of mortality and morbidity. HSMHA Health Rep 1971;86:347-354.
29. Robine JM, Jagger C, Eguidi V. A first step towards a user's guide to health expectancies for the European Union. Montpellier: Euro-Reves; June 2000.
30. Schwarzinger S, Stouthard MEA, Burström K, et al. Cross-national agreement on disability weights: the European Disability Weights project. Population Health Metrics 2003;21:1-9.
31. Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ 1999;319:1423-1425.
32. Murray CJL, López AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease study. Lancet 1997;349:1498-1504.
33. Murray CJL, López AD. Global mortality, disability and the contribution of risk factors: Global Burden of Disease study. Lancet 1997;349:1436-1442.
34. Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2002;18:19-31.
35. de Rijk MC, Tzourio C, Breteler MMB, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON collaborative study. J Neurol Neurosurg Psychiatry 1997;62:10-15.
36. Fall PA, Saleh A, Fredrickson M, Olsson JE, Granerus AK. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up. Mov Disord 2003;18: 1312-1316.
37. Elan L, Marder K, Cote L, Tang M, Mayeux R. Mortality from Parkinson's disease. Arch Neurol 1997;54:260-264.
38. Herlofson K, Lie SA, Arsland D, Larsen JP. Mortality and Parkinson's disease. Neurology 2004;62:937-942.
39. Burguera JA, Catalá J, Taberner P, Muñoz R. Mortalidad por enfermedad de Parkinson en España (1980-1985). Distribución por edades, sexo y áreas geográficas. Neurologia 1992;7:89-93.
40. De Pedro Cuesta J. Studies on the prevalence of Parálisis Agitans by tracers methodology. Acta Neurol Scand 1987;75:1-107.
41. Beyer MK, Herlofson K, Arsland D, Larsen JP. Causes of death in a community-based study of Parkinson's disease. Acta Neurol Scand 2001;103:7-11.
42. Wermuth L, Stenager EN, Stenager E, Boldsen J. Mortality in patients with Parkinson's disease. Acta Neurol Scand 1995;92:55-58.
43. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:27-442.
44. Pereira Candel J, Cañón Campos J, Alvarez Martín E, Génova Maleras R. La medida de la magnitud de los problemas de salud en el ámbito internacional: los estudios de carga de enfermedad. Rev Administracion Sanitaria 2001;5:59-84.
45. Rubenstein LM, Chrischilles EA, Voelker MD. The impact of Parkinson's disease on health status, health expenditures, and productivity. Estimates from the national medical expenditure survey. Pharmacoeconomics 1997;12:486-498.
46. Murray CJL, Lopez AD. The utility of DALY for public health policy and research: a reply. Bull World Health Organ 1997;75: 377-381.
47. Kominski GF, Simon PA, Ho A, Luck J, Lim YW, Fielding JE. Assessing the burden of disease and injury in Los Angeles County using disability-adjusted life years. Public Health Rep 2002;117: 185-191.
48. Sayers BM, Fliedner TM. The critique of DALY: a counter-reply. Bull World Health Organ 1997;75:383-384.